Final report of a phase II trial of Gemcitabine (GEM) with 5FU continous infusion (CI) in the treatment of advanced pancreatic cancer (APC)

Authors
Publication date
1 January 2002
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio Istituzionale della Ricerca- Università del Piemonte Orientale

    redirect
    oaioai:iris.uniupo.it:11579/11122
    Last time updated on 03/09/2019